ST
AEGR

Spot Trading’s Aegerion Pharmaceuticals AEGR Stock Holding History

Spot Trading’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-40,000
Closed -$759K – 4524
2015
Q2 		$759K Buy
+40,000
New +$866K 0.01% 1820
2014
Q4 		– Sell
-50,000
Closed -$1.67M – 4688
2014
Q3 		$1.67M Buy
50,000
+49,400
+8,233% +$1.53M 0.01% 1686
2014
Q2 		$19K Sell
600
-9,400
-94% -$350K ﹤0.01% 4185
2014
Q1 		$462K Buy
+10,000
New +$586K ﹤0.01% 2589

Other funds holding AEGR

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Spot Trading's AEGR Position: Q2 2015 in Review

Spot Trading sold out of Aegerion Pharmaceuticals (AEGR) in Q2 2015, closing a stake of 21,944 shares — an estimated $475K sold.

Spot Trading first reported a position in AEGR in Q2 2013 and held it in 5 quarters. The position peaked at $1.39M in Q2 2013. 97 funds tracked by Wall St. Rank hold AEGR as of Q2 2015.

  • Spot Trading reported no remaining Aegerion Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Spot Trading sold 21,944 Aegerion Pharmaceuticals shares in Q2 2015, an estimated $475K.
  • Spot Trading first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 5 quarters.
  • Spot Trading's Aegerion Pharmaceuticals position peaked at $1.39M in Q2 2013.
  • 97 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q2 2015.

Based on Spot Trading's 13F filing for Q2 2015, filed 11 Aug 2015.